Cardiac implantable electronic and other monitoring devices in continuous-flow left ventricular assist device patients. A clinical consensus statement of the Heart Failure Association and the European Heart Rhythm Association of the ESC

Amir, O.; Adamopoulos, S.; Burri, H.; Bayes-Genis, A.; Leclercq, C.; Cikes, M.; ... ; Nielsen, J.C. (2025)

Article / Letter to editor

The management of heart failure patients with continuous-flow left ventricular assist device (LVAD) patients is challenging. While one third of these patients are recipients of cardiac implantable electronic devices (CIEDs), the risk for atrial and ventricular arrhythmias may coexist. The lack of large datasets and dedicated randomized controlled trials (RCTs) focusing on LVAD and CIED implantation and management has brought medical centres to develop their own protocols and guidelines. This clinical consensus statement of the Heart Failure Association and the European Heart Rhythm Association of the ESC is a joint effort to summarize the current literature and provide advice on patient management within this field.

• Left ventricular assist device
• Cardiac implantable electronic device
• Pacemaker
• Cardiac resynchronization therapy
• Remote monitoring

• All authors: Amir, O.; Adamopoulos, S.; Burri, H.; Bayes-Genis, A.; Leclercq, C.; Cikes, M.; Egorova, A.; Peichl, P.; Fudim, M.; Rao, A.R.A.; Gustafsson, F.; Richter, S.; Pagnesi, M.; Rosano, G.; Ruschitzka, F.; Nielsen, J.C.
• Date: 2025-04-01
• Journal: European Journal of Heart Failure
• Volume: 27
• Issue: 5
• Pages: 808 - 821
• DOI: doi:10.1002/ejhf.3635